P60
Precision-cut liver slices as a model for evaluating therapeutic agents against HBV and HDV
M. Michelet, A. Roca Suarez, M. Plissonnier, A. Dubois, A. Diederichs, S. Heintz, M. Saez-Palma, M. Ben Abu, X. Grand, A. Favre, A. Chédotal, N. Van Renne, S. Fletcher, F. Mithieux, P. Bonnot, A. Dupré, N. Mouton, M. Rivoire, S. Phillips, E. Palma, S. Cho
P63
A new humanized mouse model demonstrates HBV DNA integration-driven HDV spread mimicking chronic hepatitis D
C. Hingst, M. Schäfer, T. Volz, A. Volmari, K. Riecken, L. Bitar, M. Lütgehetmann, M. Zimmermann, B. Fehse, M. Dandri, L. Allweiss
P64
Kinetics of HBcrAg during Bulevirtide monotherapy in patients with HDV-related cirrhosis: a single-center real-world study
E. Degasperi, F. Facchetti, D. Sambarino, C. Scholtes, B. Testoni, S. Uceda Renteria, MP. Anolli, C. Charre, ML. Plissonnier, R. Perbellini, A. Callegaro, M. Levrero, F. Zoulim, P. Lampertico
P71
Hepatitis-B core-related antigen (HBcrAg), phosphorylated HBcAg , and HBsAg isoforms as biomarkers of viral activity in chronic HDV infection: Do they mirror HDV RNA status?
I. Carey, Z. Cargill, M. Anderson, R. Geissler, T. Fortney, J. Lok, G. Cloherty, G. Dusheiko, K, Agarwal
P74
Discordance between two peripheral biomarkers of cccDNA transcriptional activity, namely HBV core related antigen and HBV RNA, in HBV-HDV co-infection.
J. Lok, M. Anderson, T. Fortney, Z. Cargill, G. Cloherty, J. McKeating, G. Dusheiko, K. Agarwal, I. Carey
P77
Phylogeography and epidemiological history of hepatitis delta virus genotype 3 in South America
L. Honorato, M. Gouvea, W. Braga, A. da Costa, M. Rodgers, M. Berg, C. Silveira, E. Kallas, M. Thomazella, A. de Paula, M. Castilho, Y. Rodrigues, H. Paião, M. de Freitas, L. Ribeiro, D. Dall’Acqua, J. Queiroz, J. Salcedo, T. Dantas, R. Barboza, T. Tozett